Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
David Gandara, MD & Jonathan W. Riess, MD, MS
Project Optimus and Optimizing Dose and Schedule in Early Phase Clinical Trials
Jan H. Beumer, PhD, PharmD, PhD, DABT
Changing Delivery of Chemotherapy for Breast Cancer: The Broad Impact of Antibody Drug Conjugates
Hope Rugo, MD, FASCO
Management of Neurological Toxicities from Immunotherapy: Diagnosis, Assessement and Therapy
Sajeel Chowdhary, MD
Management of Osteonecrosis of Jaw and Other Complications from Bisphosphonate and/or RANK Ligand Inhibitors
Robert E. Marx, DDS, FACS
Optimal Treatment for Early Stage HER2 Positive Breast Cancer: Tailoring Treatment to Response
Virginia Borges, MD
Sequencing Endocrine Therapy and Targeted Agents for the Treatment of Metastatic HR+/HER2- Breast Cancer
Neelima Vidula, MD
Survivorship in the Modern Era of Cancer Care: Goals, Measures, and Outcomes
Adrienne M. Vazquez Guerra, MSN, ACNP-BC, AOCN
Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma
Mohamed A. Kharfan-Dabaja, MD, MBA, FACP
